Literature DB >> 33958144

The Epidemiology of Bladder Cancer.

Matthew Mossanen1.   

Abstract

There are many risk factors for bladder cancer. During an initial assessment of a patient with bladder cancer, a careful discussion and history assessment is important. Particular focus should include social history with details regarding occupational background and discussion of any environmental exposure history.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Epidemiology; Risk factors

Mesh：

Year:  2021        PMID： 33958144     DOI： 10.1016/j.hoc.2021.02.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  8 in total

1.  Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.

Authors:  Amal S El-Shal; Sally M Shalaby; Safwat E Abouhashem; Eman H Abd Elbary; Samir Azazy; Nearmeen M Rashad; Walaa Sarhan
Journal:  Mol Biol Rep       Date:  2021-06-04       Impact factor: 2.316

2.  PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma.

Authors:  Mulin Liu; Siyi Chen; Aihui Zhang; Qin Zheng; Juan Fu
Journal:  J Inflamm Res       Date:  2021-09-15

3.  5-Methylcytosine-Related Long Noncoding RNAs Are Potential Biomarkers to Predict Overall Survival and Regulate Tumor-Immune Environment in Patients with Bladder Cancer.

Authors:  Zhuoyuan Li; Siyu Wang; Yuxian Chen; Yaozhou Huang; Tianping Li
Journal:  Dis Markers       Date:  2022-03-04       Impact factor: 3.434

4.  Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations.

Authors:  Young Joon Moon; Kang Su Cho; Jae Yong Jeong; Doo Yong Chung; Dong Hyuk Kang; Hae Do Jung; Joo Yong Lee
Journal:  PLoS One       Date:  2022-09-08       Impact factor: 3.752

5.  Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis.

Authors:  Dawei Cai; Zhongbao Zhou; Guangzhu Wei; Peishan Wu; Guangqi Kong
Journal:  Front Genet       Date:  2022-08-31       Impact factor: 4.772

6.  Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer.

Authors:  Tianhang Li; Tianyao Liu; Zihan Zhao; Yuchen Pan; Xinyan Xu; Yulin Zhang; Shoubin Zhan; Shengkai Zhou; Wenjie Zhu; Hongqian Guo; Rong Yang
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

7.  Establishment and Validation of a Tumor Microenvironment Prognostic Model for Predicting Bladder Cancer Survival Status Based on Integrated Bioinformatics Analyses.

Authors:  Qiu Chen; Guicao Yin; Xingjun He; Tianlin Jiang; Haisen Zhou; Yunjiang Wu; Yifan Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-03       Impact factor: 2.650

8.  Hope for Ostomates: A Carbon and Zeolite Impregnated Polyester Fabric Inhibits Urine Odor in Cancer Patients: A Randomized Experimental Study.

Authors:  Gianluigi Taverna; Linda M Thiel; Desiree L Miller; Lorenzo Tidu; Paolo Sardella; Patricia Camp; Matteo Luigi Zanoni; Paolo Vota; Cinzia Mazzieri; Giovanni Toia; Vittorio Fasulo; Pierpaolo Avolio; Alessio Benetti; Niccolò Buffi; Giovanni Lughezzani; Massimo Lazzeri; Paolo Casale; Giorgio Guazzoni; Fabio Grizzi; Brian Stork
Journal:  Asian Pac J Cancer Prev       Date:  2021-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.